Ipca Laboratories, 524494, IPCALAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

38,853.53
42.70
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

39,794.91
0.26%
4.99

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.99
10.52
12.77

EBITDA CAGR (%)

10 Years
5 Years
3 Years

19.83
2.43
13.09

PAT CAGR (%)

10 Years
5 Years
3 Years

22.63
-8.40
15.18

P:E (Median)

8 Years
5 Years
3 Years

37.04
42.67
50.01

P:BV (Average)

8 Years
5 Years
3 Years

4.70
4.79
4.76

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.18
20.54
21.99

Earnings Forecasts:

(Updated: 21-02-2026)

Description 2024 2025 2026 2027
Adj EPS 29.08 44.69 54.36 64.84
P/E Ratio 52.58 34.21 28.13 23.58
Revenue 8854.6 9722.11 10819 12022.8
EBITDA 1726.14 1998.9 2362.38 2726.73
Net Income 737.68 1126.49 1387.01 1659.59
ROA 6.45 9.12 10.22 11.01
P/B Ratio 5.58 4.91 4.20 3.62
ROE 11.11 14.79 15.76 16.27
FCFF 499.58 1021.74 924.8 1626.61
FCFF Yield 1.26 2.58 2.34 4.11
Net Debt 255.12 -429.87 -701.38 -1679.24
BVPS 273.88 311.1 363.91 421.98

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 1,845.18 1,662.68 10.98% 1,930.32 1,810.94 6.59% 1,746.90 1,565.86 11.56% 1,638.44 1,510.64 8.46%
Expenses 1,367.70 1,251.59 9.28% 1,465.61 1,408.83 4.03% 1,339.98 1,212.62 10.50% 1,279.85 1,218.30 5.05%
EBITDA 477.48 411.09 16.15% 464.71 402.11 15.57% 406.92 353.24 15.20% 358.59 292.34 22.66%
EBIDTM 25.88% 24.72% 24.07% 22.20% 23.29% 22.56% 21.89% 19.35%
Other Income 17.82 17.41 2.35% 21.92 17.00 28.94% 25.02 15.39 62.57% 21.49 15.10 42.32%
Interest 9.51 10.17 -6.49% 11.46 17.25 -33.57% 12.06 19.42 -37.90% 16.20 24.06 -32.67%
Depreciation 68.57 62.81 9.17% 66.86 62.65 6.72% 63.13 61.32 2.95% 65.19 61.76 5.55%
PBT 417.22 355.52 17.35% 408.31 339.21 20.37% 356.75 287.89 23.92% 17.15 127.30 -86.53%
Tax 113.77 87.96 29.34% 103.57 95.09 8.92% 94.71 83.76 13.07% 82.20 62.54 31.44%
PAT 303.45 267.56 13.41% 304.74 244.12 24.83% 262.04 204.13 28.37% -65.05 64.76 -
PATM 16.45% 16.09% 15.79% 13.48% 15.00% 13.04% -3.97% 4.29%
EPS 11.96 10.55 13.36% 12.01 9.62 24.84% 10.33 8.05 28.32% -2.56 2.55 -

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 2,392.50 2,245.37 6.55% 2,556.50 2,354.90 8.56% 2,308.85 2,092.63 10.33% 2,246.69 2,033.03 10.51%
Expenses 1,859.15 1,782.29 4.31% 2,011.58 1,913.42 5.13% 1,892.43 1,699.91 11.33% 1,817.83 1,711.13 6.24%
EBITDA 533.35 463.08 15.17% 544.92 441.48 23.43% 416.42 392.72 6.03% 428.86 321.90 33.23%
EBIDTM 22.29% 20.62% 21.32% 18.75% 18.04% 18.77% 19.09% 15.83%
Other Income 20.19 20.11 0.40% 27.86 26.26 6.09% 32.66 20.61 58.47% 25.82 18.92 36.47%
Interest 17.62 16.81 4.82% 19.61 22.56 -13.08% 18.51 24.05 -23.04% 21.51 29.37 -26.76%
Depreciation 107.59 98.46 9.27% 103.33 100.35 2.97% 100.06 98.89 1.18% 100.12 98.13 2.03%
PBT 445.98 367.92 21.22% 391.58 344.83 13.56% 330.51 290.39 13.82% 128.00 76.60 67.10%
Tax 81.93 90.59 -9.56% 108.08 99.39 8.74% 96.09 91.41 5.12% 62.22 73.69 -15.57%
PAT 364.05 277.33 31.27% 283.50 245.44 15.51% 234.42 198.98 17.81% 65.78 2.91 2,160.48%
PATM 15.22% 12.35% 11.09% 10.42% 10.15% 9.51% 2.93% 0.14%
EPS 12.86 9.78 31.49% 11.14 9.05 23.09% 9.19 7.58 21.24% 2.67 2.35 13.62%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 7,160.84 6,635.38 6,124.06 5,774.72 5,405.42 5,114.11 4,337.82 3,605.66 3,193.40 3,102.21 2,803.66 Net Sales Growth 9.32% 8.35% 6.05% 6.83% 5.70% 17.90% 20.31% 12.91% 2.94% 10.65% Cost Of Goods Sold 1,846.51 1,673.19 1,722.87 1,843.06 1,562.85 1,402.41 1,292.23 1,010.36 966.04 936.63 891.24 Gross Profit 5,314.33 4,962.19 4,401.19 3,931.66 3,842.57 3,711.70 3,045.59 2,595.30 2,227.36 2,165.58 1,912.42 GP Margin 74.21% 74.78% 71.87% 68.08% 71.09% 72.58% 70.21% 71.98% 69.75% 69.81% 68.21% Total Expenditure 5,453.14 5,145.54 4,959.25 4,886.60 4,220.01 3,663.90 3,439.48 2,926.87 2,766.48 2,703.54 2,546.14 Power & Fuel Cost - 235.60 253.33 277.21 237.44 201.48 196.82 175.25 159.89 148.93 140.03 % Of Sales - 3.55% 4.14% 4.80% 4.39% 3.94% 4.54% 4.86% 5.01% 4.80% 4.99% Employee Cost - 1,479.34 1,336.19 1,193.39 1,102.14 948.84 870.79 752.24 712.78 674.93 603.35 % Of Sales - 22.29% 21.82% 20.67% 20.39% 18.55% 20.07% 20.86% 22.32% 21.76% 21.52% Manufacturing Exp. - 692.10 709.68 626.15 588.03 501.49 449.83 363.05 359.41 400.11 380.86 % Of Sales - 10.43% 11.59% 10.84% 10.88% 9.81% 10.37% 10.07% 11.25% 12.90% 13.58% General & Admin Exp. - 290.82 284.69 271.90 239.62 223.46 233.95 261.02 262.26 237.93 212.95 % Of Sales - 4.38% 4.65% 4.71% 4.43% 4.37% 5.39% 7.24% 8.21% 7.67% 7.60% Selling & Distn. Exp. - 695.43 592.49 574.87 399.49 323.91 355.23 317.80 275.05 281.33 252.49 % Of Sales - 10.48% 9.67% 9.95% 7.39% 6.33% 8.19% 8.81% 8.61% 9.07% 9.01% Miscellaneous Exp. - 79.06 60.00 100.02 90.44 62.31 40.63 47.15 31.05 23.68 252.49 % Of Sales - 1.19% 0.98% 1.73% 1.67% 1.22% 0.94% 1.31% 0.97% 0.76% 2.33% EBITDA 1,707.70 1,489.84 1,164.81 888.12 1,185.41 1,450.21 898.34 678.79 426.92 398.67 257.52 EBITDA Margin 23.85% 22.45% 19.02% 15.38% 21.93% 28.36% 20.71% 18.83% 13.37% 12.85% 9.19% Other Income 86.25 108.50 159.77 137.34 108.76 128.60 84.16 71.57 57.70 56.52 46.27 Interest 49.23 65.06 122.58 46.34 10.41 11.13 18.84 21.09 27.46 25.99 31.11 Depreciation 263.75 251.97 246.48 228.63 209.65 187.72 178.69 171.88 174.36 171.00 161.23 PBT 1,199.43 1,281.31 955.52 750.49 1,074.11 1,379.96 784.97 557.39 282.80 258.20 111.45 Tax 394.25 349.01 291.75 244.79 213.74 239.19 132.51 102.48 49.69 69.91 18.93 Tax Rate 32.87% 34.91% 35.49% 32.62% 19.90% 17.33% 16.88% 18.39% 17.57% 27.08% 16.99% PAT 805.18 650.76 530.41 505.70 860.37 1,140.77 652.46 454.91 233.11 188.29 92.52 PAT before Minority Interest 805.18 650.76 530.41 505.70 860.37 1,140.77 652.46 454.91 233.11 188.29 92.52 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.24% 9.81% 8.66% 8.76% 15.92% 22.31% 15.04% 12.62% 7.30% 6.07% 3.30% PAT Growth 3.15% 22.69% 4.89% -41.22% -24.58% 74.84% 43.43% 95.15% 23.80% 103.51% EPS 31.74 25.65 20.91 19.93 33.91 44.97 25.72 17.93 9.19 7.42 3.65

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 9,504.54 8,896.81 7,662.43 6,204.26 5,796.74 5,394.94 4,619.03 3,745.69 3,257.76 3,156.19 2,867.11 Net Sales Growth 8.92% 16.11% 23.50% 7.03% 7.45% 16.80% 23.32% 14.98% 3.22% 10.08% Cost Of Goods Sold 2,839.39 2,444.61 2,251.73 2,079.50 1,790.78 1,547.98 1,455.41 1,090.34 978.34 939.40 903.04 Gross Profit 6,665.15 6,452.20 5,410.70 4,124.76 4,005.96 3,846.96 3,163.62 2,655.35 2,279.42 2,216.79 1,964.07 GP Margin 70.13% 72.52% 70.61% 66.48% 69.11% 71.31% 68.49% 70.89% 69.97% 70.24% 68.50% Total Expenditure 7,580.99 7,226.28 6,398.38 5,300.99 4,539.12 3,913.71 3,728.56 3,067.42 2,815.78 2,740.77 2,593.42 Power & Fuel Cost - 351.23 333.97 283.74 242.12 207.10 201.22 176.50 161.92 151.00 141.67 % Of Sales - 3.95% 4.36% 4.57% 4.18% 3.84% 4.36% 4.71% 4.97% 4.78% 4.94% Employee Cost - 1,983.99 1,708.43 1,287.64 1,177.39 1,013.57 921.23 787.40 735.88 695.98 625.58 % Of Sales - 22.30% 22.30% 20.75% 20.31% 18.79% 19.94% 21.02% 22.59% 22.05% 21.82% Manufacturing Exp. - 966.04 892.99 655.66 610.03 524.21 471.80 374.26 366.92 404.52 387.75 % Of Sales - 10.86% 11.65% 10.57% 10.52% 9.72% 10.21% 9.99% 11.26% 12.82% 13.52% General & Admin Exp. - 387.39 345.05 296.10 261.34 242.22 249.90 271.85 268.52 246.68 219.87 % Of Sales - 4.35% 4.50% 4.77% 4.51% 4.49% 5.41% 7.26% 8.24% 7.82% 7.67% Selling & Distn. Exp. - 917.41 745.87 595.47 402.81 324.86 359.15 317.84 277.62 280.74 249.22 % Of Sales - 10.31% 9.73% 9.60% 6.95% 6.02% 7.78% 8.49% 8.52% 8.89% 8.69% Miscellaneous Exp. - 175.61 120.34 102.88 54.65 53.77 69.85 49.23 26.58 22.45 249.22 % Of Sales - 1.97% 1.57% 1.66% 0.94% 1.00% 1.51% 1.31% 0.82% 0.71% 2.31% EBITDA 1,923.55 1,670.53 1,264.05 903.27 1,257.62 1,481.23 890.47 678.27 441.98 415.42 273.69 EBITDA Margin 20.24% 18.78% 16.50% 14.56% 21.70% 27.46% 19.28% 18.11% 13.57% 13.16% 9.55% Other Income 106.53 151.32 184.36 151.77 121.72 129.19 86.50 74.66 58.08 54.76 40.77 Interest 77.25 87.84 140.75 48.19 11.20 12.27 19.77 22.24 27.57 26.91 34.56 Depreciation 411.10 397.82 357.24 261.56 232.42 209.17 210.50 182.42 177.73 172.95 163.26 PBT 1,296.07 1,336.19 950.42 745.29 1,135.72 1,388.98 746.70 548.27 294.76 270.32 116.64 Tax 348.32 343.61 313.46 253.36 224.77 240.14 135.33 104.24 51.11 67.52 20.44 Tax Rate 26.88% 30.38% 37.20% 33.99% 19.79% 17.29% 18.12% 19.01% 17.34% 24.98% 17.52% PAT 947.75 739.97 553.64 484.26 905.24 1,147.71 606.32 445.58 239.42 194.54 96.20 PAT before Minority Interest 916.54 787.53 529.21 491.93 910.95 1,148.84 603.56 442.22 239.42 194.54 96.20 Minority Interest -31.21 -47.56 24.43 -7.67 -5.71 -1.13 2.76 3.36 0.00 0.00 0.00 PAT Margin 9.97% 8.32% 7.23% 7.81% 15.62% 21.27% 13.13% 11.90% 7.35% 6.16% 3.36% PAT Growth 30.79% 33.66% 14.33% -46.50% -21.13% 89.29% 36.07% 86.11% 23.07% 102.22% EPS 37.36 29.17 21.82 19.09 35.68 45.24 23.90 17.56 9.44 7.67 3.79

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 6,891.62 6,348.71 5,877.30 5,475.76 4,752.72 3,677.54 3,136.66 2,694.94 2,475.12 2,283.05 Share Capital 25.37 25.37 25.37 25.37 25.37 25.27 25.27 25.24 25.24 25.24 Total Reserves 6,866.25 6,323.34 5,851.93 5,450.39 4,727.35 3,640.33 3,111.39 2,669.38 2,449.88 2,257.81 Non-Current Liabilities 759.77 790.39 891.89 608.95 191.82 265.43 307.04 420.11 546.49 661.70 Secured Loans 482.43 542.19 651.78 395.18 9.13 64.21 133.94 234.01 347.22 433.63 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 14.17 0.00 0.00 4.52 50.65 Long Term Provisions 57.76 50.49 46.57 42.34 37.29 30.98 25.28 25.88 24.55 20.22 Current Liabilities 1,417.60 1,520.17 1,677.78 1,353.73 1,065.59 1,241.60 1,013.84 992.65 946.34 959.88 Trade Payables 481.53 422.74 450.84 491.95 526.46 537.85 464.09 414.75 388.06 415.24 Other Current Liabilities 606.45 586.34 470.42 407.05 278.51 294.88 266.94 262.00 315.35 296.09 Short Term Borrowings 154.95 368.53 626.90 337.58 147.47 309.27 195.86 239.04 177.30 182.86 Short Term Provisions 174.67 142.56 129.62 117.15 113.15 99.60 86.95 76.86 65.63 65.69 Total Liabilities 9,068.99 8,659.27 8,446.97 7,438.44 6,010.13 5,184.57 4,457.54 4,107.70 3,967.95 3,904.63 Net Block 2,536.97 2,523.70 2,478.66 2,153.09 1,868.60 1,840.97 1,740.10 1,854.61 1,945.97 1,976.58 Gross Block 4,387.79 4,157.07 3,880.12 3,370.69 2,888.47 2,679.08 2,412.97 2,358.72 2,276.99 2,137.32 Accumulated Depreciation 1,850.82 1,633.37 1,401.46 1,201.76 1,004.03 838.11 672.87 504.11 331.02 160.74 Non Current Assets 5,252.87 5,149.38 3,571.82 3,203.52 2,732.34 2,472.46 2,171.99 2,200.54 2,256.30 2,304.86 Capital Work in Progress 489.65 175.20 123.02 297.15 182.00 84.19 65.96 73.23 94.87 128.93 Non Current Investment 2,041.32 2,243.56 733.41 619.39 474.01 410.47 231.86 146.28 98.01 97.43 Long Term Loans & Adv. 164.40 186.16 227.77 119.21 183.45 125.65 128.11 119.19 105.98 86.20 Other Non Current Assets 20.53 20.76 8.96 14.68 24.28 11.18 5.96 7.23 11.47 15.72 Current Assets 3,779.94 3,509.89 4,875.15 4,224.46 3,277.79 2,712.11 2,285.55 1,907.16 1,711.65 1,599.77 Current Investments 651.94 410.60 323.32 719.31 393.83 238.25 90.38 69.35 113.57 0.00 Inventories 1,542.39 1,677.09 1,660.13 1,779.54 1,517.09 1,266.96 1,055.55 873.17 873.54 831.93 Sundry Debtors 1,154.61 1,027.40 925.90 824.30 774.46 839.13 632.06 594.38 501.98 441.45 Cash & Bank 164.53 112.92 1,706.06 595.50 306.92 152.40 259.81 131.03 17.53 161.98 Other Current Assets 266.47 99.86 111.10 110.73 285.49 215.37 247.75 239.23 205.03 164.41 Short Term Loans & Adv. 199.72 182.02 148.64 195.08 209.20 94.47 170.23 173.64 134.86 96.93 Net Current Assets 2,362.34 1,989.72 3,197.37 2,870.73 2,212.20 1,470.51 1,271.71 914.51 765.31 639.89 Total Assets 9,032.81 8,659.27 8,446.97 7,427.98 6,010.13 5,184.57 4,457.54 4,107.70 3,967.95 3,904.63

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 6,948.45 6,332.19 5,842.02 5,464.84 4,701.65 3,627.48 3,122.39 2,688.57 2,455.26 2,259.19 Share Capital 25.37 25.37 25.37 25.37 25.37 25.27 25.27 25.24 25.24 25.24 Total Reserves 6,920.38 6,305.21 5,816.65 5,439.47 4,676.28 3,590.27 3,097.12 2,663.01 2,430.02 2,233.95 Non-Current Liabilities 969.14 1,014.41 901.72 613.87 189.69 290.29 313.40 419.42 548.32 662.57 Secured Loans 543.24 580.41 651.78 395.18 9.13 88.80 133.94 234.01 347.22 433.63 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 14.17 6.91 0.00 4.52 50.64 Long Term Provisions 96.31 86.84 46.99 42.73 38.56 32.23 25.28 25.88 24.55 20.22 Current Liabilities 2,384.29 2,355.64 1,805.82 1,465.88 1,160.54 1,326.42 1,097.50 1,007.57 955.93 969.95 Trade Payables 846.17 776.08 525.06 557.70 664.86 609.85 524.32 423.47 396.54 421.11 Other Current Liabilities 725.45 732.62 488.15 420.52 204.49 304.57 274.74 266.75 316.41 297.50 Short Term Borrowings 495.25 559.24 661.82 367.81 176.61 310.95 209.69 239.04 177.30 184.85 Short Term Provisions 317.42 287.70 130.79 119.85 114.58 101.05 88.75 78.31 65.68 66.49 Total Liabilities 11,741.70 11,097.05 8,622.86 7,621.51 6,066.41 5,257.82 4,548.83 4,115.56 3,959.51 3,891.71 Net Block 4,266.81 4,553.53 2,751.38 2,402.19 2,072.43 2,058.73 1,940.38 1,952.96 1,983.27 2,014.18 Gross Block 6,994.56 7,020.79 4,353.42 3,749.46 3,201.39 2,985.73 2,632.86 2,464.33 2,318.22 2,176.95 Accumulated Depreciation 2,727.75 2,467.26 1,602.04 1,331.43 1,113.12 927.00 692.48 511.37 334.95 162.77 Non Current Assets 5,475.09 5,558.15 3,433.59 3,164.34 2,629.45 2,402.11 2,171.08 2,170.08 2,217.69 2,269.79 Capital Work in Progress 621.77 342.89 140.43 306.43 234.82 133.28 66.33 73.00 94.64 128.74 Non Current Investment 216.32 303.61 302.66 269.88 111.43 71.31 30.05 17.52 22.24 25.82 Long Term Loans & Adv. 317.29 315.59 229.61 169.63 185.64 127.61 128.36 119.37 106.07 85.14 Other Non Current Assets 52.90 42.53 9.51 16.21 25.13 11.18 5.96 7.23 11.47 15.91 Current Assets 5,967.04 5,535.55 5,189.27 4,446.71 3,436.96 2,855.71 2,377.75 1,945.48 1,741.81 1,621.92 Current Investments 763.39 558.40 323.32 719.31 393.83 238.25 90.38 69.35 113.57 0.00 Inventories 2,560.42 2,471.31 1,743.37 1,857.97 1,594.81 1,323.12 1,072.50 880.59 882.22 837.42 Sundry Debtors 1,873.82 1,686.51 989.02 910.78 811.75 895.20 681.51 602.27 500.16 445.87 Cash & Bank 344.23 296.84 1,853.24 640.66 365.07 180.92 282.30 150.57 35.85 175.54 Other Current Assets 425.18 325.01 124.70 116.19 271.50 218.22 251.06 242.70 210.01 163.09 Short Term Loans & Adv. 304.93 197.48 155.62 201.80 193.23 162.29 170.70 174.44 138.60 95.86 Net Current Assets 3,582.75 3,179.91 3,383.45 2,980.83 2,276.42 1,529.29 1,280.25 937.91 785.88 651.97 Total Assets 11,442.13 11,093.70 8,622.86 7,611.05 6,066.41 5,257.82 4,548.83 4,115.56 3,959.50 3,891.71

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,374.07 830.51 762.29 831.72 1,096.06 561.43 495.65 323.86 271.14 696.00 PBT 999.77 822.16 750.49 1,074.11 1,379.96 784.97 557.39 282.80 258.20 111.45 Adjustment 605.78 399.16 206.09 221.16 172.50 180.77 174.79 185.03 161.82 201.27 Changes in Working Capital 93.27 -113.86 20.96 -271.39 -214.53 -257.90 -128.87 -86.56 -94.56 412.34 Cash after chg. in Working capital 1,698.82 1,107.46 977.54 1,023.88 1,337.93 707.84 603.31 381.27 325.46 725.06 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -324.75 -276.95 -215.25 -192.16 -241.87 -146.41 -107.66 -57.41 -54.32 -29.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -738.81 -1,355.18 -709.61 -814.00 -559.56 -499.13 -122.98 -119.34 -145.55 -213.62 Net Fixed Assets -545.17 -329.13 -335.30 -597.37 -307.20 -284.34 -46.98 -60.09 -105.61 466.60 Net Investments -39.10 -1,597.43 281.97 -470.86 -219.12 -326.48 -106.61 -4.05 -114.15 -15.57 Others -154.54 571.38 -656.28 254.23 -33.24 111.69 30.61 -55.20 74.21 -664.65 Cash from Financing Activity -428.44 -464.88 506.38 426.04 -307.38 -138.67 -222.83 -130.43 -156.39 -414.16 Net Cash Inflow / Outflow 206.82 -989.55 559.06 443.76 229.12 -76.37 149.84 74.09 -30.80 68.22 Opening Cash & Equivalents 515.28 1,504.83 945.77 499.86 272.07 348.44 198.60 124.51 155.31 87.09 Closing Cash & Equivalent 722.10 515.28 1,504.83 945.77 501.19 272.07 348.44 198.60 124.51 155.31

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,321.32 944.65 805.81 856.07 1,090.13 570.35 501.03 341.13 281.91 708.65 PBT 1,131.14 842.67 745.29 1,135.72 1,388.98 738.89 546.46 290.53 262.06 116.64 Adjustment 727.89 489.87 235.18 195.11 183.07 247.37 187.36 192.51 174.86 211.11 Changes in Working Capital -176.46 -91.59 48.99 -272.72 -236.33 -263.69 -121.97 -84.44 -103.73 410.30 Cash after chg. in Working capital 1,682.57 1,240.95 1,029.46 1,058.11 1,335.72 722.57 611.85 398.60 333.19 738.05 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -361.25 -296.30 -223.65 -202.04 -245.59 -152.22 -110.82 -57.47 -51.28 -29.40 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -869.50 -1,291.79 -725.00 -855.05 -520.69 -509.65 -165.06 -135.40 -148.82 -218.33 Net Fixed Assets -545.17 -329.13 -335.30 -597.37 -307.20 -284.34 -46.98 -60.09 -105.61 466.60 Net Investments -39.10 -1,597.43 281.97 -470.86 -219.12 -326.48 -106.61 -4.05 -114.15 -15.57 Others -285.23 634.77 -671.67 213.18 5.63 101.17 -11.47 -71.26 70.94 -669.36 Cash from Financing Activity -282.98 -552.55 507.24 426.78 -305.82 -136.54 -183.20 -130.41 -159.13 -461.51 Net Cash Inflow / Outflow 168.84 -899.69 588.05 427.80 263.62 -75.84 152.77 75.32 -26.04 28.81 Opening Cash & Equivalents 755.79 1,578.98 990.93 559.01 295.39 370.92 218.15 142.83 168.87 140.06 Closing Cash & Equivalent 924.63 755.79 1,578.98 990.93 559.01 295.39 370.92 218.15 142.83 168.87

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 271.64 250.24 231.66 215.84 187.34 290.11 248.25 213.52 196.13 180.91 ROA 7.34% 6.20% 6.37% 12.79% 20.38% 13.53% 10.62% 5.77% 4.78% 2.39% ROE 9.83% 8.68% 8.91% 16.82% 27.10% 19.18% 15.60% 9.02% 7.91% 4.10% ROCE 13.97% 12.78% 11.77% 19.34% 30.54% 20.84% 16.76% 9.53% 8.97% 4.52% Fixed Asset Turnover 1.56 1.53 1.60 1.74 1.85 1.72 1.52 1.39 1.43 1.24 Receivable days 59.63 57.81 54.93 53.65 57.30 61.48 61.61 62.15 54.52 51.03 Inventory Days 87.98 98.77 107.96 110.63 98.87 97.05 96.88 99.02 98.55 112.26 Payable days 98.63 88.26 83.21 103.53 123.17 47.09 49.40 50.05 51.96 52.98 Cash Conversion Cycle 48.99 68.31 79.68 60.75 33.00 111.44 109.09 111.12 101.10 110.31 Total Debt/Equity 0.13 0.18 0.24 0.14 0.05 0.12 0.14 0.23 0.29 0.38 Interest Cover 16.37 7.71 17.20 104.18 124.99 42.67 27.43 11.30 10.93 4.58

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 273.78 249.53 230.27 215.41 185.32 286.15 247.12 213.02 194.55 179.02 ROA 6.90% 5.37% 6.06% 13.31% 20.29% 12.47% 10.25% 6.03% 5.17% 2.50% ROE 11.86% 8.70% 8.70% 17.92% 27.63% 18.15% 15.28% 9.47% 8.60% 4.31% ROCE 15.27% 13.10% 11.71% 20.46% 30.92% 19.92% 16.53% 9.94% 9.44% 4.82% Fixed Asset Turnover 1.28 1.35 1.54 1.68 1.75 1.65 1.48 1.37 1.43 1.23 Receivable days 72.68 63.37 55.52 53.92 57.48 61.90 62.09 61.27 53.75 50.16 Inventory Days 102.72 99.83 105.25 108.09 98.25 94.05 94.47 97.98 97.70 110.76 Payable days 121.11 102.19 86.04 111.16 136.39 49.85 51.13 50.35 52.23 52.92 Cash Conversion Cycle 54.30 61.01 74.74 50.86 19.34 106.10 105.43 108.90 99.22 108.00 Total Debt/Equity 0.19 0.22 0.25 0.14 0.05 0.13 0.15 0.23 0.29 0.38 Interest Cover 13.88 6.99 16.47 102.40 114.20 38.77 25.65 11.69 11.05 4.38

Top Investors:

hdfc mutual fund - hdfc mid-cap fund

dsp midcap fund

kotak midcap fund

sbi life insurance co. ltd

nippon life india trustee ltd- a/c nippon india growth mid cap fund

hdfc life insurance company limited

kotak funds - india midcap fund

investor education and protection fund (iepf)

llp

Annual Reports:

News Update:

Ipca Laboratories - Quarterly Results
14th Feb 2026, 00:00 AM

Read More
Ipca Laboratories receives USFDA’s EIR for Tarapur API facility
9th Feb 2026, 12:48 PM

The EIR classifies the manufacturing facility as ‘Voluntary Action Indicated’
Read More
USFDA conducts inspection at Ipca Laboratories’ APIs manufacturing facility at Tarapur
5th Dec 2025, 16:42 PM

At the conclusion of the inspection, USFDA has issued a Form 483 with 3 observations
Read More

Ipca Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524494 | NSE: IPCALAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Ipca Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524494 | NSE: IPCALAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: